Role of positron emission tomography in thyroid and neuroendocrine tumors

Medicine and Dentistry

• Positron Emission Tomography 100%
• Neoplasm 54%
• Thyroid Tumor 54%
• Radioactive Tracer 45%
• Inpatient 36%
• Diagnosis 27%
• Endocrine Tumor 27%
• Fluorine-18 27%
• Gallium 68 27%
• Magnetic Resonance Imaging 18%
• Metabolism 18%
• Peptide 18%
• Fluorodeoxyglucose F 18 18%
• Iodine 124 18%
• Tetraxetan 18%
• Precursor 9%
• Morphology 9%
• Receptor 9%
• Imaging Technique 9%
• Pheochromocytoma 9%
• Amine 9%
• Paraganglioma 9%
• Iodine 9%
• Glucose Metabolism 9%
• Somatostatin Derivative 9%
• Hybrid 9%
• Somatostatin Receptor 9%
• Receptor Expression 9%
• Multiple Endocrine Neoplasia 9%
• Lung Tumor 9%
• Dosimetry 9%
• Fluorodeoxyglucose 9%
• Positron Emission Tomography-Computed Tomography 9%
• Functional Imaging 9%
• Peptide Receptor 9%
• Patient 9%
• Oncology 9%
• Computed Tomography 9%
• Radionuclide Therapy 9%
• Neuroendocrine Tumor 9%